)
glp 1 latest Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight The Latest on GLP-1s |
Description
At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk
March 17, 2026
We love it
See which health clubs already do, plus the integration models, vendors, and compliance in the quarterly Inspire360 report.
